Sienkiewicz, B., Urbaniak-Kujda, D., Dybko, J., Dryś, A., Hurkacz, M., Wróbel, T., & Wiela-Hojeńska, A. (2017). Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT. Pathol Oncol Res.
Stile di citazione ChicagoSienkiewicz, Beata, Donata Urbaniak-Kujda, Jarosław Dybko, Andrzej Dryś, Magdalena Hurkacz, Tomasz Wróbel, e Anna Wiela-Hojeńska. "Influence of CYP2C19 Genotypes On the Occurrence of Adverse Drug Reactions of Voriconazole Among Hematological Patients After Allo-HSCT." Pathol Oncol Res 2017.
Citazione MLASienkiewicz, Beata, et al. "Influence of CYP2C19 Genotypes On the Occurrence of Adverse Drug Reactions of Voriconazole Among Hematological Patients After Allo-HSCT." Pathol Oncol Res 2017.